These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 6573537)

  • 1. Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice.
    Malkinson AM; Beer DS
    J Natl Cancer Inst; 1983 May; 70(5):931-6. PubMed ID: 6573537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic and genetic studies on the modulatory effects of butylated hydroxytoluene on mouse lung adenoma formation.
    Malkinson AM; Beer DS
    J Natl Cancer Inst; 1984 Oct; 73(4):925-33. PubMed ID: 6592388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations.
    Karasaki H; Obata M; Ogawa K; Lee GH
    Oncogene; 1997 Oct; 15(15):1833-40. PubMed ID: 9362450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of strain and age on prophylaxis and co-carcinogenesis of urethan-induced mouse lung adenomas by butylated hydroxytoluene.
    Malkinson AM; Thaete LG
    Cancer Res; 1986 Apr; 46(4 Pt 1):1694-7. PubMed ID: 3948160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in the proliferation of murine pulmonary type II cells: basal rates and alterations following urethan treatment.
    Thaete LG; Beer DG; Malkinson AM
    Cancer Res; 1986 Oct; 46(10):5335-8. PubMed ID: 3756882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine chromosomal localization of the mouse Par2 gene that confers resistance against urethane-induction of pulmonary adenomas.
    Lee GH; Matsushita H; Kitagawa T
    Oncogene; 2001 Jul; 20(30):3979-85. PubMed ID: 11494126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic resistance to urethan-induced pulmonary adenomas in SMXA recombinant inbred mouse strains.
    Pataer A; Nishimura M; Kamoto T; Ichioka K; Sato M; Hiai H
    Cancer Res; 1997 Jul; 57(14):2904-8. PubMed ID: 9230199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of early chemically-induced pulmonary lesions in mice of varying susceptibilities to lung tumorigenesis.
    O'Donnell EP; Zerbe LK; Dwyer-Nield LD; Kisley LR; Malkinson AM
    Cancer Lett; 2006 Sep; 241(2):197-202. PubMed ID: 16337739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the Par2 (Pulmonary adenoma resistance) locus on mouse chromosome 18, a major genetic determinant for lung carcinogen resistance in BALB/cByJ mice.
    Obata M; Nishimori H; Ogawa K; Lee GH
    Oncogene; 1996 Oct; 13(8):1599-604. PubMed ID: 8895504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice.
    Ryan J; Barker PE; Nesbitt MN; Ruddle FH
    J Natl Cancer Inst; 1987 Dec; 79(6):1351-7. PubMed ID: 2891865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J x BALB/c mice.
    Festing MF; Lin L; Devereux TR; Gao F; Yang A; Anna CH; White CM; Malkinson AM; You M
    Genomics; 1998 Oct; 53(2):129-36. PubMed ID: 9790761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice.
    Manenti G; Galbiati F; Giannì-Barrera R; Pettinicchio A; Acevedo A; Dragani TA
    Oncogene; 2004 May; 23(25):4495-504. PubMed ID: 15064703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular derivation of lung tumors in sensitive and resistant strains of mice: results at 28 and 56 weeks after urethan treatment.
    Thaete LG; Gunning WT; Stoner GD; Malkinson AM
    J Natl Cancer Inst; 1987 Apr; 78(4):743-9. PubMed ID: 3470549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2-controlled genetic susceptibility to pulmonary adenomas induced by urethane and 4-nitroquinoline 1-oxide in A/Wy congenic strains.
    Miyashita N; Moriwaki K
    Jpn J Cancer Res; 1987 May; 78(5):494-8. PubMed ID: 3112061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of various strains of mice to urethan-induced lung tumors and depressed natural killer cell activity.
    Gorelik E; Herberman RB
    J Natl Cancer Inst; 1981 Dec; 67(6):1317-22. PubMed ID: 6947114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines.
    Wang M; Lemon WJ; Liu G; Wang Y; Iraqi FA; Malkinson AM; You M
    Cancer Res; 2003 Jun; 63(12):3317-24. PubMed ID: 12810665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice.
    Dragani TA; Manenti G; Della Porta G
    Cancer Res; 1991 Dec; 51(23 Pt 1):6299-303. PubMed ID: 1933890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in liver tumor susceptibility, plasma testosterone levels, and androgen receptor binding in six inbred strains of mice.
    Kemp CJ; Drinkwater NR
    Cancer Res; 1989 Sep; 49(18):5044-7. PubMed ID: 2766275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different genetic susceptibility to aberrant crypts and colon adenomas in mice.
    Moen CJ; van der Valk MA; Bird RP; Hart AA; Demant P
    Cancer Res; 1996 May; 56(10):2382-6. PubMed ID: 8625315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression.
    Manenti G; Gariboldi M; Fiorino A; Zanesi N; Pierotti MA; Dragani TA
    Cancer Res; 1997 Oct; 57(19):4164-6. PubMed ID: 9331067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.